| A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA K Ewer, T Rampling, N Venkatraman, G Bowyer, D Wright, T Lambe, ... New England Journal of Medicine 374 (17), 1635-1646, 2016 | 301 | 2016 |
| Local and systemic responses to SARS-CoV-2 infection in children and adults M Yoshida, KB Worlock, N Huang, RGH Lindeboom, CR Butler, ... Nature 602 (7896), 321-327, 2022 | 239 | 2022 |
| Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults C Ogwang, D Kimani, NJ Edwards, R Roberts, J Mwacharo, G Bowyer, ... Science translational medicine 7 (286), 286re5-286re5, 2015 | 162 | 2015 |
| Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals SH Hodgson, KJ Ewer, CM Bliss, NJ Edwards, T Rampling, ... The Journal of infectious diseases 211 (7), 1076-1086, 2015 | 157 | 2015 |
| Malaria-induced interferon-γ drives the expansion of Tbethi atypical memory B cells N Obeng-Adjei, S Portugal, P Holla, S Li, H Sohn, A Ambegaonkar, ... PLoS pathogens 13 (9), e1006576, 2017 | 151 | 2017 |
| A monovalent chimpanzee adenovirus Ebola vaccine—preliminary report T Rampling, K Ewer, G Bowyer, D Wright, E Imoukhuede, R Payne, ... New England Journal of Medicine, 2015 | 139 | 2015 |
| Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara … T Rampling, KJ Ewer, G Bowyer, CM Bliss, NJ Edwards, D Wright, ... The Journal of infectious diseases 214 (5), 772-781, 2016 | 88 | 2016 |
| First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children AB Tiono, I Nébié, N Anagnostou, AS Coulibaly, G Bowyer, E Lam, ... PloS one 13 (12), e0208328, 2018 | 82 | 2018 |
| Activation-induced Markers Detect Vaccine-Specific CD4+ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials G Bowyer, T Rampling, J Powlson, R Morter, D Wright, AVS Hill, KJ Ewer Vaccines 6 (3), 50, 2018 | 78 | 2018 |
| Prime and target immunization protects against liver-stage malaria in mice A Gola, D Silman, AA Walters, S Sridhar, S Uderhardt, AM Salman, ... Science translational medicine 10 (460), eaap9128, 2018 | 75 | 2018 |
| Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations D Kimani, YJ Jagne, M Cox, E Kimani, CM Bliss, E Gitau, C Ogwang, ... Molecular Therapy 22 (11), 1992-2003, 2014 | 72 | 2014 |
| Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal N Venkatraman, BP Ndiaye, G Bowyer, D Wade, S Sridhar, D Wright, ... The Journal of infectious diseases 219 (8), 1187-1197, 2019 | 68 | 2019 |
| Safety and efficacy of novel malaria vaccine regimens of RTS, S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP T Rampling, KJ Ewer, G Bowyer, NJ Edwards, D Wright, S Sridhar, ... NPJ vaccines 3 (1), 49, 2018 | 55 | 2018 |
| Viral vector malaria vaccines induce high-level T cell and antibody responses in West African children and infants CM Bliss, A Drammeh, G Bowyer, GS Sanou, YJ Jagne, O Ouedraogo, ... Molecular Therapy 25 (2), 547-559, 2017 | 55 | 2017 |
| A review of phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines? T Lambe, G Bowyer, KJ Ewer Philosophical Transactions of the Royal Society B: Biological Sciences 372 …, 2017 | 51 | 2017 |
| Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP CM Bliss, G Bowyer, NA Anagnostou, T Havelock, CM Snudden, H Davies, ... Scientific reports 8 (1), 3390, 2018 | 50 | 2018 |
| HLA-E: exploiting pathogen-host interactions for vaccine development HR Sharpe, G Bowyer, S Brackenridge, T Lambe Clinical & Experimental Immunology 196 (2), 167-177, 2019 | 36 | 2019 |
| CXCR3+ T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and … G Bowyer, A Grobbelaar, T Rampling, N Venkatraman, D Morelle, ... Frontiers in immunology 9, 1660, 2018 | 35 | 2018 |
| Safety and immunogenicity of malaria vectored vaccines given with routine expanded program on immunization vaccines in Gambian infants and neonates: a randomized controlled trial VA Mensah, S Roetynck, EK Kanteh, G Bowyer, A Ndaw, F Oko, CM Bliss, ... Frontiers in immunology 8, 1551, 2017 | 32 | 2017 |
| Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™ N Venkatraman, N Anagnostou, C Bliss, G Bowyer, D Wright, ... Vaccine 35 (45), 6208-6217, 2017 | 32 | 2017 |
